Immunogenicity 14285
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
CPSF2
Transcript ID
NM_017437
HLA INFO
C*12:03
TCR INFO
No TCR info found!
Full length protein sequence (782 aa)
MTSII
1
KLTTL
6
SGVQE
11
ESALC
16
YLLQV
21
DEFRF
26
LLDCG
31
WDEHF
36
SMDII
41
DSLRK
46
HVHQI
51
DAVLL
56
SHPDP
61
LHLGA
66
LPYAV
71
GKLGL
76
NCAIY
81
ATIPV
86
YKMGQ
91
MFMYD
96
LYQSR
101
HNTED
106
FTLFT
111
LDDVD
116
AAFDK
121
IQQLK
126
FSQIV
131
NLKGK
136
GHGLS
141
ITPLP
146
AGHMI
151
GGTIW
156
KIVKD
161
GEEEI
166
VYAVD
171
FNHKR
176
EIHLN
181
GCSLE
186
MLSRP
191
SLLIT
196
DSFNA
201
TYVQP
206
RRKQR
211
DEQLL
216
TNVLE
221
TLRGD
226
GNVLI
231
AVDTA
236
GRVLE
241
LAQLL
246
DQIWR
251
TKDAG
256
LGVYS
261
LALLN
266
NVSYN
271
VVEFS
276
KSQVE
281
WMSDK
286
LMRCF
291
EDKRN
296
NPFQF
301
RHLSL
306
CHGLS
311
DLARV
316
PSPKV
321
VLASQ
326
PDLEC
331
GFSRD
336
LFIQW
341
CQDPK
346
NSIIL
351
TYRTT
356
PGTLA
361
RFLID
366
NPSEK
371
ITEIE
376
LRKRV
381
KLEGK
386
ELEEY
391
LEKEK
396
LKKEA
401
AKKLE
406
QSKEA
411
DIDSS
416
DESDI
421
EEDID
426
QPSAH
431
KTKHD
436
LMMKG
441
EGSRK
446
GSFFK
451
QAKKS
456
YPMFP
461
APEER
466
IKWDE
471
YGEII
476
KPEDF
481
LVPEL
486
QATEE
491
EKSKL
496
ESGLT
501
NGDEP
506
MDQDL
511
SDVPT
516
KCIST
521
TESIE
526
IKARV
531
TYIDY
536
EGRSD
541
GDSIK
546
KIINQ
551
MKPRQ
556
LIIVH
561
GPPEA
566
SQDLA
571
ECCRA
576
FGGKD
581
IKVYM
586
PKLHE
591
TVDAT
596
SETHI
601
YQVRL
606
KDSLV
611
SSLQF
616
CKAKD
621
AELAW
626
IDGVL
631
DMRVS
636
KVDTG
641
VILEE
646
GELKD
651
DGEDS
656
EMQVE
661
APSDS
666
SVIAQ
671
QKAMK
676
SLFGD
681
DEKET
686
GEESE
691
IIPTL
696
EPLPP
701
HEVPG
706
HQSVF
711
MNEPR
716
LSDFK
721
QVLLR
726
EGIQA
731
EFVGG
736
VLVCN
741
NQVAV
746
RRTET
751
GRIGL
756
EGCLC
761
QDFYR
766
IRDLL
771
YEQYA
776
IV
781
Mutation Information
DNA mutation:
None
Peptide Range:
511 ~ 535
Mut AA position:
523 (13 in Wild Type peptide)
Alignment
Wild Type:
"MDQDLSDVPTKCISTTESIEIKARV
||||||||||||.||||||||||||
Mutant:
MDQDLSDVPTKCVSTTESIEIKARV"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) CPSF2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay